Cargando...
Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo
Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (om...
Gardado en:
| Publicado en: | J Lipid Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The American Society for Biochemistry and Molecular Biology
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446708/ https://ncbi.nlm.nih.gov/pubmed/30782959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M091173 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|